Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Glenmark Pharmaceuticals Ltd.
NSE: GLENMARK
|
BSE: 532296
|
ISIN: INE935A01035
|
Industry: Pharmaceuticals
|
Mid-range Performer
1939.3000
3.70
(
0.19
%)
NSE
Oct 10, 2025
15:31 PM
52.04% Gain from 52W Low
Volume:
867.4K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Glenmark Pharmaceuticals Ltd.
16 May 2017
1939.30
0.19%
BP Equities Glenmark Pharma Ltd Q4FY17 Result Upd
Hold:
Glenmark Pharmaceuticals Ltd.
by
BP Wealth
Target: 877
BP Wealth
Glenmark Pharmaceuticals Ltd. has gained
40.72%
in the last 6 Months
More from Glenmark Pharmaceuticals Ltd.
Recommended
Five Interesting Stocks Today - October 10, 2025
The Baseline |
10 Oct 2025
Market closes higher, Capacit'e Infra bags Rs 542 cr order from IIT Bombay
Trendlyne Marketwatch |
10 Oct 2025
Earnings Call Transcript - Q4FY20 for Glenmark Pharmaceuticals
|
29 Jun 2020